Skip to main content
SpringerLink
Log in

Role of nitric oxide in tumor progression: Lessons from experimental tumors

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

Nitric oxide (NO), a potent biological mediator, plays a key role in physiological as well as pathological processes, including inflammation and cancer. The role of NO in tumor biology remains incompletely understood. While a few reports indicate that the presence of NO in tumor cells or their microenvironment is detrimental to tumor cell survival and consequently their metastatic ability, a large body of clinical and experimental data suggest a promoting role of NO in tumor progression and metastasis. We suggest that tumor cells capable of very high levels of NO production die in vivo, and those producing or exposed to lower levels of NO, or capable of resisting NO-mediated injury undergo a clonal selection because of their survival advantage; they also utilize certain NO-mediated mechanisms for promotion of growth, invasion and metastasis. The possible mechanism(s) are: (a) a stimulatory effect on tumor cell invasiveness, (b) a promotion of tumor angiogenesis and blood flow in the tumor neovasculature, and (c) a suppression of host anti-tumor defense. In this review, we discuss these mechanisms on the basis of data derived from experimental models, in particular, a mouse mammary tumor model in which the expression of eNOS by tumor cells is positively correlated with invasive and metastatic abilities. Tumor-derived NO was shown to promote tumor cell invasiveness and angiogenesis. The invasion-stimulating effects of NO were due to an upregulation of matrix metalloproteases and a downregulation of their natural inhibitors. Treatment of tumor-bearing mice with NO-blocking agents reduced the growth and vascularity of primary tumors and their spontaneous metastases. We propose that selected NO-blocking drugs may be useful in treating certain human cancers either as single agents or as a part of combination therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fidler IJ, Radinsky R: Editorial: Genetic control of cancer metastasis. J Nat Cancer Inst 82: 166-168, 1990

    PubMed  Google Scholar 

  2. Nicolson GI: Cancer progression and growth: Relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp Cell Res 204: 171-180, 1993

    Article  PubMed  Google Scholar 

  3. Folkman J: What is the evidence that tumors are angiogenesis dependent. J Nat Cancer Inst 82: 4-7, 1990

    PubMed  Google Scholar 

  4. Stetler-Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Ann Rev Cell Biol 9: 541-573, 1993

    PubMed  Google Scholar 

  5. Dedhar S: Integrin mediated signal transduction in oncogenesis: an overview. Cancer Met Rev 14: 165-172, 1995

    Google Scholar 

  6. MacDougall JR, Matrisian LM: Contribution of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Met Rev 14: 351-362, 1995

    Google Scholar 

  7. Akiyama SK, Olden K, Yamada KM: Fibronectin and integrins in invasion and metastasis. Cancer Met Rev 14: 173- 189, 1995

    Google Scholar 

  8. Turley EA: Hyaluronan anc cell locomotion. Cancer Met Rev 11: 21-30, 1992

    Google Scholar 

  9. Chambers AF, Macdonald IC, Schmidt EE, Koop S, Morris VL, Khokha R, Groom AC: Steps in tumor metastasis: New concepts in intravital videomicroscopy. Cancer Met Rev 14: 279-301, 1995

    Google Scholar 

  10. Palmer RMJ, Ferrige AS, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987

    Article  PubMed  Google Scholar 

  11. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 377-386, 1980

    Google Scholar 

  12. Furchgot RF: Studies on endothelium-dependent vasodilation and the endothelium-derived relaxing factor. Acta Physiol Scand 139: 257-270, 1990

    PubMed  Google Scholar 

  13. Moncada S, Palmer RMJ, Higgs EA: Byosynthesis of nitric oxide from L-arginine: a pathway for the regulation of cell function and communication. Biochem Pharmacol 38: 1709-1715, 1989

    Article  PubMed  Google Scholar 

  14. Malietta MA: Nitric oxide: biosynthesis and biological significance. Trends Biochem Sci 14: 488-492, 1989

    Article  PubMed  Google Scholar 

  15. Snyder SH, Bredt DS: Biological roles of nitric oxide. Sci Am 266: 68-71, 1992

    Google Scholar 

  16. Nathan CF, Hibbs JB Jr.: Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3: 65-70, 1991

    Article  PubMed  Google Scholar 

  17. Stuehr DJ, Nathan CF: Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 469: 1543-1555, 1989

    Article  Google Scholar 

  18. Tamir S, Tannenbaum SR: The role of nitric oxide (NO) in the carcinogenetic process. BBA 1288: f31-f36, 1996

    PubMed  Google Scholar 

  19. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993

    Article  PubMed  Google Scholar 

  20. Knowles RG, Moncada S: Nitric oxide synthases in mammals. Biochem J 298: 249-258, 1994

    PubMed  Google Scholar 

  21. Kobik L, Schmidt HHHW: Immunohistochemistry of nitric oxide synthase and nitric oxide related products. In: Feelisch M, Stamler J (eds) Methods in Nitric Oxide, John Wiley & Sons, New York 1996, pp 229-236

    Google Scholar 

  22. Morris SM, Billiar TR: New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 266: E829-E839, 1994

    PubMed  Google Scholar 

  23. Billiar TR: Nitric oxide: Novel biology with clinical relevance. Ann Surg 221: 339-349, 1995

    PubMed  Google Scholar 

  24. Albina JE: On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukocyte Biol 58: 643-649, 1995

    PubMed  Google Scholar 

  25. Tschugguel W, Knogler W, Czerwenka K, Mildner M, Weninger W, Zeillinger R, Huber JC: Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia. Br J Cancer 74: 1423-1426, 1996

    PubMed  Google Scholar 

  26. Goldstein S, Yang G-Y, Yang CS: Time dependent expression of inducible nitric oxide synthase (iNOS) in a rat model of Barrett’s esophagus and adenocarcinoma of the esophagus. Proc Amer Assoc Cancer Res 38: 353, 1997 (Abstract)

    Google Scholar 

  27. Miles D, Thomsen L, Balkwill F, Thavasu P, Moncada S: Association between biosynthesis of nitric oxide and changes in immunological and vascular parameters in patients treated with interleukin-2. Eur J Clin Invest 24: 287-290, 1994

    PubMed  Google Scholar 

  28. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S: Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54: 1352-1354, 1994

    PubMed  Google Scholar 

  29. Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA: Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 55: 727-730, 1995

    PubMed  Google Scholar 

  30. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S: Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41-44, 1995

    PubMed  Google Scholar 

  31. Chhatwal VJS, Ngoi SS, Chan STF, Chia YW, Moochhala SM: Aberrant expression of nitric oxide synthase in human polyps, neoplastic colonic mucosa an surrounding peritumoral normal mucosa. Carcinogenesis 15: 2081-2085, 1994

    PubMed  Google Scholar 

  32. Moochhala S, Chhatwal VJS, Chan STF, Ngoi SS, Chia YW, Rauff A: Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 17: 1171-1174, 1996

    PubMed  Google Scholar 

  33. Jenkins DC, Charles IG, Baylis SA, Lelchuk R, Rodomski MW, Moncada S: Human colon cancer cell lines show a diverse pattern on nitric oxide synthase gene expression and nitric oxide generation. Brit J Cancer 70: 847-849, 1994

    PubMed  Google Scholar 

  34. Buttery LDK, Springall DR, Andrade SP, Riveros-Moreno V, Hart I, Piper PJ, Polak JM: Induction of nitric oxide synthase in the neo-vasculature of experimental tumours in mice. J Path 171: 311-319, 1993

    PubMed  Google Scholar 

  35. Kennovin GD, Hirst DG, Stratford MRL, Flitney FW: Inducible nitric oxide synthase is expressed in tumour-associated vasculature: inhibition retards tumor growth in vivo. In: Moncada S, Feelisch M, Busse R, Higgs EA (eds) Biology of Nitric Oxide, Part 4: Enzymology, Biochemistry and Immunology. Portland Press, London, 1994, pp 473-479

    Google Scholar 

  36. Orucevic A, Lala PK: Effects of NG-Methyl-L-Arginine, an inhibitor of nitric oxide synthesis, on IL-2 induced capillary leakage and anti-tumor responses in healthy and tumor bearing mice. Cancer Immunol Immunother 42: 38-46, 1996

    Article  PubMed  Google Scholar 

  37. Orucevic A, Lala PK: NG-Nitro-L-Arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin-2 induced capillary leakage and reduces tumor growth in adenocarcinoma bearing mice. Br J Cancer 72: 189-197, 1996

    Google Scholar 

  38. Edwards P, Cendan JC, Topping DB, Moldawer LL, Mackay S, Copeland EM, Lind DS: Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J Surg Res 63: 49-52, 1996

    Article  PubMed  Google Scholar 

  39. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S: Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 82: 4392-4396, 1995

    Google Scholar 

  40. Dong Z, Staroselsky AH, Qi X, Xie K, Fidler IJ: Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res 54: 789-793, 1994

    PubMed  Google Scholar 

  41. Xie K, Huang S, Dong Z, Juang S-H, Gutman M, Xie Q-W, Nathan C, Fidler IJ: Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogated metastasis by K-1735 murine melanoma cells. J Exp Med 181: 1333-1343, 1995

    Article  PubMed  Google Scholar 

  42. Santer V, Mastramarino JH, Lala PK: Characterization of lymphocyte subsets in spontaneous mouse mammary tumors and host lymphoid organs. In J Cancer 25: 159-168, 1980

    Google Scholar 

  43. Gallahan D, Kozak C, Callahan R: A new common integration region (int 3) for mouse mammary tumor virus on chromosome 17. J Virol 61: 218-220, 1987

    PubMed  Google Scholar 

  44. Morris VL, Rao TR, Kozak CA, Gray DA, Leechan ECM, Connel TJ, Baylor CB, Jones RF, McGrath CM: Characterization of int-5, a locus associated with early events in mammary carcinogenesis. Oncogene Res 6: 53-63, 1991

    PubMed  Google Scholar 

  45. Brodt P, Lala PK: Studies on clonal heterogeneity in two spontaneously metastasizing mammary carcinomas of recent origin. Int J Cancer 35: 265-273, 1985

    PubMed  Google Scholar 

  46. Lala PK, Parhar RS, Singh P: Indomethacin therapy abrogates prostaglandin mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis. Cell Immunol 99: 108-118, 1986

    PubMed  Google Scholar 

  47. Lala PK, Parhar RS: Eradication of spontaneous and experimental adenocarcinoma metastasis with chronic indomethacin and intermittant IL-2 therapy. Int J Cancer 54: 677-684, 1993

    PubMed  Google Scholar 

  48. Forrester K, Ambs S, Lupold SE, Kapust RB, Spillare EA, Weinberg WC, Felly Bosco E, Wang XW, Geller DA, Tzeng E, Billiar TR, Harris C: Nitric oxide induced p53 accumulation of regulation of inducible nitric oxide synthase expression by wild type p53. Proc Natl Acad Sci USA 93: 2442-2447, 1996

    Article  PubMed  Google Scholar 

  49. Ambs S, Merriam WG, Bennett WP, Ogunfusika M, Hussain SP, Tzeng E, Geller DA, Billiar TR, Harris CC: Interaction of nitric oxide and p53 in tumor growth: a putative model for clonal selection of mutant p53 cells. Proc Amer Assoc Cancer Res 38: 273, 1997 (Abstract)

    Google Scholar 

  50. Sveinbjornsson B, Olsen R, Seternes OM, Seljelid R: Macrophage cytotoxicity against murine meth A sacroma involves nitric oxide mediated apoptosis. Biochem Biophys Res Commun 223: 643-649, 1996

    Article  PubMed  Google Scholar 

  51. Li L, Kilbourn RG, Adams J, Fidler IJ: Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells. Cancer Res 51: 245-254, 1991

    PubMed  Google Scholar 

  52. Xie K, Huang S, Dong Z, Fidler IJ: Cytokine-induced apoptosis in transformed murine fibroblasts involves synthesis of endogenous nitric oxide. Intern J Oncol 3: 1043-1047, 1993

    Google Scholar 

  53. Brune B, Mohr S, Messmer UK: Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide (NO) signaling pathways. Rev Physiol Biochem Pharmacol 127: 1-30, 1996

    PubMed  Google Scholar 

  54. Ho YS, Wang YJ, Lin JK: Induction of p53 and p21/WAF1/C1P1 expression by nitric oxide and their association with apoptosis in human cancer cells. Mol Carcinogen 16: 20-31, 1996

    Google Scholar 

  55. Albina JE, Martin BA, Henry WL Jr, Louis CA, Reichner JS: B cell lymphoma-2 transfected P815 cells resist reactive nitrogen intermediate-mediated macrophage-dependent cytotoxicity. J Immunol 157: 279-283, 1996

    PubMed  Google Scholar 

  56. Xie K, Huang S, Wang Y, Bethran PJ, Juang SH, Dong Z, Reed JC, McDonnell TJ, McConkey DJ, Fidler IJ: Bcl-2 protects cells from cytokine-induced nitric oxide-dependent apoptosis. Cancer Immunol Immunother 43: 109-115, 1996

    Article  PubMed  Google Scholar 

  57. Orucevic A, Lala PK: Nitric oxide production by murine mammary adenocarcinoma cells promotes tumor cell invasiveness. Proc Amer Assoc Cancer Res 37: 77, 1996 (Abstract)

    Google Scholar 

  58. Murrell GAG, Jang D, Williams RJ: Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 206: 15-21, 1995

    Article  PubMed  Google Scholar 

  59. Tamura T, Takanishi Y, Kimura Y, Sasaki K, Norimatsu H, Takahashi K, Takigawa M: Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes. A possible mechanism of pathological neovascularization in arthritis. Endocrinology 137: 3729-3737, 1996

    Article  PubMed  Google Scholar 

  60. Ziche M, Morbidelli L, Donnini S, Presta M, Granger HG: Nitric oxide increases the expression of endogenous bFGF in post capillary venule endothelial cells. Proc Amer Assoc Cancer Res 38: 524, 1997 (Abstract)

    Google Scholar 

  61. Xie K, Fidler IJ: Decreased matrix metalloproteanase-2 (MMP-2) expression correlates with the suppression of tumorigenicity and metastasis of K-1735 murine melanoma cells transfected with the inducible nitric oxide synthase (iNOS). Proc Amer Assoc Cancer Res 38: 166, 1997 (Abstract)

    Google Scholar 

  62. Pipili-Synetos E, Sakkoula E, Haralabopoulos G, Andriopoulou P, Peristeris P, Maragoudakis ME: Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 111: 894-902, 1994

    PubMed  Google Scholar 

  63. Konturek SJ, Brzozowski T, Majka J, Pytko-Polonczyk J, Stachura J: Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Eur J Pharm 239: 215-217, 1993

    Article  PubMed  Google Scholar 

  64. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F: Nitric oxide mediates angiogenesis in vivoand endothelial cell growth and migration in vitropromoted by substance P. J Clin Invest 94: 2036-2044, 1994

    PubMed  Google Scholar 

  65. Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, Koch AE: Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase dependent effector mechanism. Proc Nat Acad Sci USA 91: 4190-4194, 1994

    PubMed  Google Scholar 

  66. Morbidelli L, Chang C-H, Douglas JG, Granger JH, Ledda F, Ziche M: Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 39: H411-H415, 1996

    Google Scholar 

  67. Doi K, Akaike T, Horie H, Noguchi Y, Fujii S, Beppu T, Ogawa M, Maeda H: Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth. Cancer 77: 1598-1604, 1996

    PubMed  Google Scholar 

  68. Kibbey MC, Grant DS, Kleinman HK: Role of SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivomatrigel model. J Natl Cancer Inst 84: 1633-1638, 1992

    PubMed  Google Scholar 

  69. Stuehr DJ, Marletta MA: Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia colilipopolysaccharide. Proc Nat Acad Sci USA 82: 7738-7742, 1985

    PubMed  Google Scholar 

  70. Keller R, Geiges M, Keist R: L-arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages. Cancer Res 50: 1421-1425, 1990

    PubMed  Google Scholar 

  71. Liew FY, Millot S, Parkinson C, Palmer RMJ, Moncada S: Macrophage killing of Leishmariaparasite in vivois mediated by nitric oxide from L-arginine. J Immunol 144: 4794-4797, 1990

    PubMed  Google Scholar 

  72. Mills CD, Shearer J, Evans R, Caldwell MD: Macrophage arginine metabolism and inhibition or stimulation of cancer. J Immunol 149: 2709-2714, 1992

    PubMed  Google Scholar 

  73. Cifone MG, Festiccia C, Cironi L, Cavallo G, Chessa MA, Pensa V, Tubaro E, Santoni A: Induction of the nitric oxidesynthesizing pathway in fresh and interleukin 2-cultured rat natural killer cells. Cell Immunol 157: 181-194, 1994

    Article  PubMed  Google Scholar 

  74. Xiao L, Eneroth PH, Qureshi GA: Nitric oxide synthase pathway may mediate human natural killer cell cytotoxicity. Scand J Immunol 42: 505-511, 1995

    PubMed  Google Scholar 

  75. Filep JG, Baron C, Lachance S, Perreault C, Chan JS: Involvement of nitric oxide in target cell lysis and DNA fragmentation induced by murine natural killer cells. Blood 87: 5136-5143, 1996

    PubMed  Google Scholar 

  76. Hoffman RA, Langrehr JM, Billiar TR, Curran RD, Simmons RL: Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol 145: 2220-2226, 1990

    PubMed  Google Scholar 

  77. Albina JE, Abate JA, Henry WL Jr.: Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: role of IFN-??in the induction of nitric oxide-synthesizing pathway. J Immunol 147: 144-148, 1991

    PubMed  Google Scholar 

  78. Lejeune P, Lagadec P, Onier N, Pinard D, Ohshima H, Jeannin J-F: Nitric oxide involvement in tumor-induced immunosuppression. J Immunol 152: 5077-5083, 1994

    PubMed  Google Scholar 

  79. Orucevic A, Lala PK: Effects of NG-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2 induced LAK cell generation in vivoand in vitroin healthy and tumor-bearing mice. Cell Immunol 169: 126-132, 1996

    Article  Google Scholar 

  80. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996

    Article  PubMed  Google Scholar 

  81. McLillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L: A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 182: 1683-1693, 1995

    Article  PubMed  Google Scholar 

  82. Ambs S, Hussain SP, Harris CC: Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J 11: 443-448, 1997

    PubMed  Google Scholar 

  83. Hollstein M, Sidransky D, Vogelstein B, Harris CC: P53 mutations in human cancer. Science 253: 49-53, 1991

    PubMed  Google Scholar 

  84. Kim Y-M, Bergonia H, Lancaster JR Jr.: Nitrogen oxide-induced autoprotection in isolated rat hepatocytes. FEBS Lett 374: 228-232, 1995

    Article  PubMed  Google Scholar 

  85. Brüne B, Gölkel C, vonKnethen A: Cytokine and low-level nitric oxide prestimulation block p53 accumulation and apoptosis of raw 264.7 macrophages. Biochem Biophys Res Commun 229: 396-401, 1996

    Article  PubMed  Google Scholar 

  86. Lala PK, Al-Mutter N, Orucevic A: Effects of chronic indomethacin therapy on the development and progression of spontaneous mammary tumors in C3H/HCJ mice. Int J Cancer 73: 371-380, 1997

    Article  PubMed  Google Scholar 

  87. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not fibroblast growth factor-induced angiogenesis. J Clin Invest 99: 2625-2634, 1997

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anatomy and Cell Biology, The University of Western Ontario, London, Ontario, Canada

    Peeyush K. Lala & Amila Orucevic

Authors
  1. Peeyush K. Lala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amila Orucevic
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lala, P.K., Orucevic, A. Role of nitric oxide in tumor progression: Lessons from experimental tumors. Cancer Metastasis Rev 17, 91–106 (1998). https://doi.org/10.1023/A:1005960822365

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005960822365

Search

Navigation